Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

Autor: Eduardo Bergel, Alejandra Debonis, Ignacio Esteban, Sofia Jares Baglivo, Sofia Sol Aranda, Ramiro Manuel Larrea, Jorge Lantos, Nicolás Kreplak, Candela Etchegaray, Yvonne Ritou, Mabel Berrueta, Ricardo Valentini, Fernando Althabe, Pablo Cruz, Gabriel Leberzstein, Alvaro Ciganda, Sofia Lujan Laudanno, Damian Alvarez Paggi, Fernando Alvez, Susana Pastor Arguello, Luz Gibbons, Alejandra Hintze, M Laura Oyarvide, Clara Sanchez Yanotti, Miguel Santiago Gonzalez, Romina Libster, Gaston Ofman, Federico Cesar Etchenique, Rocio Lopez Castelo, Cristian Wood, Fernando P. Polack, Maria Dolores Silveyra, Alejandra Neira, Ivonne Name, Sebastian Esperante, Gisela Caruso, Nicolas Itcovici, Julian De Luca, Silvina Coviello, Anibal Rondan, Rocio Rodriguez, Valeria Fernandez Vina, Gabriela Lescano, Gonzalo Pérez Marc, Federico Dimase, Dario Raul Alvarez, Virginia Braem, Alejandra Bianchi, Julieta Alfonso, Sofia Rapelius, Adrián Ferreti, Eduardo Perez, Mauricio T. Caballero, Juan Molinos, Diego Wappner, Florencia Nowogrodzki

Publikováno v: New England Journal of Medicine
The New England Journal of Medicine
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET

BACKGROUND: Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19) remain elusive. Among them, convalescent plasma administered to hospitalized patients has been unsuccessful, perhaps because antibodies should be administ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::616e8d871c02399c474be2d5daf4bebf
https://doi.org/10.1056/nejmoa2033700